Moradi-Azhgil Reza, Sayadi Neda, Haghighi Shayesteh, Moradi Parya
Department of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Tanaffos. 2024 Apr;23(4):392-402.
The novel coronavirus 2019 primarily affects the respiratory system and may lead to respiratory failure and the need for intubation. This study aimed to investigate the effect of chest physiotherapy on the clinical outcomes of patients with COVID-19.
This randomized clinical trial was performed in 2022-2023. The research population included 58 patients with COVID-19 who were hospitalized at Izeh Shohada Hospital, Khuzestan. Patients in the control group received routine care, which included the use of supportive drugs based on the doctor's opinion, oxygen therapy, and nutritional support. The intervention group received chest physiotherapy and breathing exercises for six days. At the end of the third and sixth days, the patients of both groups were evaluated in terms of lung function, respiratory gases, and the length of hospital stay. Moreover, the need for intubation was recorded during study time. Data analysis was done using SPSS version 23 software.
In the intervention group, a significant improvement was observed in FVC (P<0.01), FEV(P<0.01), FEV/FVC ratio (P<0.01), PaO (P<0.01), PaCO (P<0.01), and SPO (P<0.01) as well as the length of hospital stay (P<0.01) after the intervention. However, no significant difference was observed in the PaO2/FiO ratio (P>0.05) and the need for intubation (P>0.05).
The results showed that in the new crisis resulting from COVID-19, chest physiotherapy and respiratory exercises could be used as a helpful method in improving lung function, respiratory gases, and reducing the hospital stay in COVID-19 patients.
2019年新型冠状病毒主要影响呼吸系统，可能导致呼吸衰竭并需要插管。本研究旨在探讨胸部物理治疗对新型冠状病毒肺炎（COVID-19）患者临床结局的影响。
本随机临床试验于2022年至2023年进行。研究人群包括58例在胡齐斯坦省伊泽赫烈士医院住院的COVID-19患者。对照组患者接受常规护理，包括根据医生意见使用支持性药物、氧疗和营养支持。干预组接受为期六天的胸部物理治疗和呼吸锻炼。在第三天和第六天结束时，对两组患者的肺功能、呼吸气体和住院时间进行评估。此外，在研究期间记录插管需求。使用SPSS 23版软件进行数据分析。
干预后，干预组的用力肺活量（FVC，P<0.01）、第一秒用力呼气容积（FEV，P<0.01）、FEV/FVC比值（P<0.01）、动脉血氧分压（PaO，P<0.01）、动脉血二氧化碳分压（PaCO，P<0.01）、血氧饱和度（SPO，P<0.01）以及住院时间（P<0.01）均有显著改善。然而，氧合指数（PaO2/FiO比值，P>0.05）和插管需求（P>0.05）方面未观察到显著差异。
结果表明，在COVID-19引发的新危机中，胸部物理治疗和呼吸锻炼可作为改善COVID-19患者肺功能、呼吸气体和缩短住院时间的有益方法。
